Delivery Order SPE2DB24D2013-SPE2DB25FCKDW
- Not listed
- The Defense Logistics Agency awarded a $1,629.66 delivery order to AmerisourceBergen Drug Corp for XYOSTED 50 mg/0.5 mL auto-injector supplies, with a completion date of July 31, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The place...
- The Defense Logistics Agency awarded a $1,167.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp for XYOSTED 50 mg/0.5 ml auto-injector units, with a completion date of September 15, 2025. This non-set-aside competitive award represents a single delivery order transaction under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical distributor,...
- The Defense Logistics Agency awarded a delivery order valued at $1,655.80 to AmerisourceBergen Drug Corp for XYOSTED 75 mg/0.5 mL auto-injector units on July 28, 2025, with completion expected by July 29, 2025. This delivery order represents a firm fixed-price purchase with no set-aside designation, indicating the award was made through open competition. The pharmaceutical product will be delivered to the place of performance located in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $1,524.90 to AmerisourceBergen Drug Corp for XYOSTED 75 mg/0.5 ml auto-injector supplies on July 18, 2025, with completion targeted for July 21, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award based on capability. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical delivery order. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,358.05 to AmerisourceBergen Drug Corp for XYOSTED 50 MG/0.5 ML auto-injectors (0.5 ML) on July 29, 2025, with an ultimate completion date of July 30, 2025. This firm fixed-price delivery order was not set-aside and competitively awarded. The product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order valued at $1,150.15 to AmerisourceBergen Drug Corp for XYOSTED 75 mg/0.5 mL auto-injector supplies. The contract, which is non-set-aside and competitively awarded, was issued on August 1, 2025, with an ultimate completion date of August 4, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order operates under...
- The Defense Logistics Agency (DLA) awarded a $1,365.12 firm fixed-price delivery order to AmerisourceBergen Drug Corp for XYOSTED 75 mg/0.5 mL auto-injector pharmaceutical supplies. This non-set-aside award, issued on August 25, 2025, with completion targeted for August 26, 2025, represents a single delivery transaction under AmerisourceBergen's existing DLA contract vehicle. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order worth $1,472.66 to AmerisourceBergen Drug Corporation's Corporate Office division. The order is for 4565470089 XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which allows the agency to efficiently procure a comprehensive range of medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,119.17 to AmerisourceBergen Drug Corp for the supply of XYOSTED 75 mg/0.5 ml auto-injector vials, with an ultimate completion date of August 11, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a $2,935.72 delivery order to AmerisourceBergen Drug Corp for XYOSTED 75 mg/0.5 mL auto-injectors on September 4, 2025, with a completion date of September 5, 2025. This competitively awarded, firm fixed-price order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's...
- SPE2DB24D2013Indefinite Delivery Contract
- SPE2DB24D2013-SPE2DB25FCKDWDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,238.22 to AmerisourceBergen Drug Corp for XYOSTED 75 mg/0.5 mL auto-injector supplies, with an ultimate completion date of September 15, 2025. This is a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a substantial value of $999,999,999.00 through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems. The company's DLA Troop Support contract enables it to supply a wide range of pharmaceutical products and medical supplies, including specialty medications, vaccines, and medical devices across multiple therapeutic domains. All of AmerisourceBergen's federal contract awards reviewed were non-set-aside and competitively awarded, demonstrating the company's capability to meet rigorous federal procurement standards. The DLA Troop Support is planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, potentially involving at least three different contractors to support customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 9/12/25 |